ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
2 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
166
|
56K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
baldwidx
|
1.0K |
531K |
0 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
1.0K
|
531K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
baldwidx
|
10K |
4.7M |
27 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
10K
|
4.7M
|
27
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
baldwidx
|
10K |
4.7M |
0 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
10K
|
4.7M
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
7 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
166
|
56K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
1 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
166
|
56K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Katelin’s Turn is HERE!!!
|
|
baldwidx
|
237 |
125K |
17 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
237
|
125K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
19 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
166
|
56K
|
19
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
8 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
166
|
56K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
10 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
166
|
56K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
10 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
166
|
56K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
6 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
166
|
56K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
2 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
166
|
56K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
4 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
166
|
56K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
2 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
166
|
56K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
0 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
166
|
56K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
1 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
166
|
56K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
3 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
166
|
56K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
3 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
166
|
56K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
7 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
166
|
56K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
baldwidx
|
10K |
4.7M |
0 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
10K
|
4.7M
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
baldwidx
|
10K |
4.7M |
2 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
10K
|
4.7M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
5 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
166
|
56K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
2 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
166
|
56K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
14 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
166
|
56K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
9 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
166
|
56K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
5 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
166
|
56K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
32 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
166
|
56K
|
32
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
baldwidx
|
166 |
56K |
10 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
166
|
56K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Katelin’s Turn is HERE!!!
|
|
baldwidx
|
237 |
125K |
24 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
237
|
125K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
baldwidx
|
10K |
4.7M |
2 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
10K
|
4.7M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: AGM Chair Address & CEO Presentation
|
|
baldwidx
|
76 |
32K |
0 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
76
|
32K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
baldwidx
|
605 |
272K |
20 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
605
|
272K
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
baldwidx
|
605 |
272K |
28 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
605
|
272K
|
28
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
baldwidx
|
605 |
272K |
6 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
605
|
272K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
baldwidx
|
605 |
272K |
5 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
605
|
272K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: AGM Chair Address & CEO Presentation
|
|
baldwidx
|
76 |
32K |
4 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
76
|
32K
|
4
|
|
ASX - By Stock
|
HAV |
Re:
Ann: Molybdenum Discovery Near Kalkaroo
|
|
baldwidx
|
13 |
3.9K |
1 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
13
|
3.9K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: AGM Chair Address & CEO Presentation
|
|
baldwidx
|
76 |
32K |
0 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
76
|
32K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
baldwidx
|
605 |
272K |
0 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
605
|
272K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
baldwidx
|
605 |
272K |
4 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
605
|
272K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
baldwidx
|
605 |
272K |
4 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
605
|
272K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: AGM Chair Address & CEO Presentation
|
|
baldwidx
|
76 |
32K |
5 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
76
|
32K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
baldwidx
|
10K |
4.7M |
7 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
10K
|
4.7M
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
baldwidx
|
1.0K |
531K |
15 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
1.0K
|
531K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Results of Meeting
|
|
baldwidx
|
3 |
1.8K |
11 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
3
|
1.8K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Ann: AGM Chair Address & CEO Presentation
|
|
baldwidx
|
76 |
32K |
0 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
76
|
32K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: AGM Chair Address & CEO Presentation
|
|
baldwidx
|
76 |
32K |
44 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
76
|
32K
|
44
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
|
|
baldwidx
|
160 |
78K |
8 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
160
|
78K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
baldwidx
|
1.0K |
531K |
5 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
1.0K
|
531K
|
5
|
|